IHT Wealth Management’s Immunomedics Inc IMMU Stock Holding History

IHT Wealth Management’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-33,500	Closed	-$2.85M	–	781
2020 Q3	$2.85M	Sell	33,500 -10,965	-25%	-$555K	0.29%	80
2020 Q2	$1.58M	Sell	44,465 -12,500	-22%	-$365K	0.22%	107
2020 Q1	$768K	Sell	56,965 -9,217	-14%	-$155K	0.11%	198
2019 Q4	$1.4M	Sell	66,182 -6,565	-9%	-$116K	0.17%	146
2019 Q3	$965K	Buy	72,747 +3,230	+5%	+$47.5K	0.13%	178
2019 Q2	$964K	Hold	69,517	–	–	0.14%	161
2019 Q1	$1.33M	Hold	69,517	–	–	0.22%	111
2018 Q4	$992K	Buy	+69,517	New	+$1.38M	0.19%	132

IHT Wealth Management's IMMU Position: Q4 2020 in Review

IHT Wealth Management sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 33,500 shares — an estimated $2.85M sold.

IHT Wealth Management first reported a position in IMMU in Q4 2018 and held it in 8 quarters. The position peaked at $2.85M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

IHT Wealth Management reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
IHT Wealth Management sold 33,500 Immunomedics Inc shares in Q4 2020, an estimated $2.85M.
IHT Wealth Management first reported a position in Immunomedics Inc in Q4 2018 and held it in 8 quarters.
IHT Wealth Management's Immunomedics Inc position peaked at $2.85M in Q3 2020.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on IHT Wealth Management's 13F filing for Q4 2020, filed 17 Feb 2021.